3 Year Returns
17.96%
NAV (₹)
123.4863
1 Day NAV Change
-0.34%
Nippon India Pharma Fund IDCW is a scheme from Nippon India Mutual Fund AMC, launched on 05 Jun 2004 and currently managing ₹ 9479.08 Cr in assets. It sits in the very high risk category on the riskometer, with a minimum SIP of ₹100 and a lump sum of ₹5000. The sections below cover its latest NAV, historical returns, portfolio holdings, and expense ratio.
Nippon India Pharma Fund IDCW Fund Details
| Min. SIP Amount | ₹ 100 |
| Min. Lumpsum Amount | ₹ 5000 |
| AUM | ₹ 9479.08 Cr |
| Expense Ratio | 1.84% |
| Lock-in Period | No Lock-in Period |
| Inception Date | 05 Jun 2004 |
| Fund Age | 22 Yrs |
Exit Load
1% if redeemed or switched out on or before completion of 1 Months from the date of allotment of units. Nil if redeemed or switched out after the completion of 1 Months from the date of allotment of units.
Fund’s Investment Objective
The primary investment objective of the Scheme is to generate consistent returns by investing in equity / equity related or fixed income securities of Pharma and other associated companies
Calculate Your Mutual Fund Returns
Returns Estimator
Estimation is based on the past performance
Expected Rate of Return
The value of your investment after 5 Years will be
₹4,12,432
Invested Amount
₹3,00,000
Est. Returns
₹1,12,432
Scheme’s Historical Return
Asset Allocation
AUM
₹1,33,309.00 Cr
Cash Holdings
21.45%
Equity
70.84%
Cash
21.45%
Debt
1.71%
Other
6%
Nippon India Pharma Fund IDCW Sector Holdings
Last Updated: 31 Aug 2026| Sectors | Allocation | Weightage | Value (in Cr.) |
|---|---|---|---|
| Pharmaceuticals | 75.50% | ₹ 7,156.714 | |
| Healthcare | 21.93% | ₹ 2,079.161 | |
| Retail | 2.57% | ₹ 243.201 |
Nippon India Pharma Fund IDCW Stock Holdings
Last Updated: 31 Aug 2026| Name | Allocation | Weightage | Value (in Cr.) | Sector |
|---|---|---|---|---|
| Sun Pharma.Inds. | 12.37% | ₹ 1,172.292 | Pharmaceuticals | |
| Divi's Lab. | 7.00% | ₹ 663.404 | Pharmaceuticals | |
| Lupin | 6.43% | ₹ 609.249 | Pharmaceuticals | |
| Cipla | 6.09% | ₹ 577.075 | Pharmaceuticals | |
| Apollo Hospitals | 5.15% | ₹ 488.345 | Healthcare | |
| Dr Reddy's Labs | 4.93% | ₹ 467.503 | Pharmaceuticals | |
| Mankind Pharma | 4.09% | ₹ 387.934 | Pharmaceuticals | |
| Sai Life | 3.94% | ₹ 373.062 | Pharmaceuticals | |
| Ajanta Pharma | 3.47% | ₹ 329.184 | Pharmaceuticals | |
| Glaxosmi. Pharma | 3.31% | ₹ 313.996 | Pharmaceuticals |
Fund Manager Details
Risk-O-Meter
Investors understand that their principal will be at Very High Risk
Risk Scale
AMC Information
Nippon India Mutual Fund
Funds Managed
108
Assets Managed
₹ 7,67,506.42 Cr
Contact Details
Registered Address
4th Floor, Tower A, Peninsula Busines-s Park, Ganapatrao Kadam MargLower Parel (W), Mumbai - 400013.
Managing Director
Mr. Upendra Kumar Sinha
Chief Executive Officer
Mr. Sundeep Sikka
Compliance Officer
Mr. Muneesh Sud
Mutual Funds Calculators
Explore Mutual Funds by Types
Open NFOs
Explore Popular AMCs
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
Download the AR Invest App
- 5000+ Schemes
- Personalized Solutions
- Expert Insights
